GLUCOSE- dextrose monohydrate injection 
Baxter Healthcare Corporation

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Glucose 5% w/v Intravenous Infusion BP*
in VIAFLO container

HEALTH CARE PROVIDER LETTER

DHCP Letter 1
DHCP Letter 2
DHCP Letter 3
DHCP Letter 4
DHCP Letter 5
DHCP Letter 6
DHCP Letter 7
DHCP Letter 8
DHCP Letter 9
DHCP Letter 10
DHCP Letter 11
DHCP Letter 12
DHCP Letter 13
DHCP Letter 14

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Glucose FE0086G Representative Container Label

Container Label

Baxter Logo
FE0086G
Viaflo
50 ml
Glucose 5% w/v
Intravenous Infusion BP

pH 4.2 (approx.)
Isotonic
Osmolarity 278 m0sm/l (approx.)
Formula per 50 ml
Glucose (as monohydrate) 2.5 g Water for Injections
IV administration
Read package leaflet before use Keep out of the sight
and reach of children Do not remove from overwrap
until ready for use Do not administer simultaneously
with blood through the same infusion equipment Do not
use unless solution is clear without visible particles and
container undamaged Do not reconnect partially used
bags Do not store above 30ºC
Baxter Healthcare Ltd
Caxton Way Thetford Norfolk IP24 3SE POM 07
0
United Kingdom
PA 167/9/30
PL 00116/0335
MA 161/00205
UN-35-03-130

Bar Code
5 413760 277639
LOT
EXP

Glucose FE0087 Representative Container Label

Container Label

Baxter Logo
FE0087
Viaflo
100 ml
Glucose 5% w/v
Intravenous Infusion BP

pH 4.2 (approx.)
Isotonic
Osmolarity 278 m0sm/l (approx.)
Formula per 100 ml
Glucose (as monohydrate) 5.0 g Water for Injections
IV administration
Read package leaflet before use Keep out of the sight
and reach of children Do not remove from overwrap
until ready for use Do not administer simultaneously
with blood through the same infusion equipment Do not
use unless solution is clear without visible particles and
container undamaged Do not reconnect partially used
bags Do not store above 30ºC
Baxter Healthcare Ltd
Caxton Way Thetford Norfolk IP24 3SE POM 07
0
United Kingdom
PA 167/9/30
PL 00116/0335
MA 161/00205
UN-35-03-130

Bar Code
5 413760 277639
LOT
EXP

GLUCOSE 
dextrose monohydrate injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-9547
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE2.5 g  in 50 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0338-9547-5075 in 1 CARTON10/05/201710/05/2017
150 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage10/05/201710/05/2017
GLUCOSE 
dextrose monohydrate injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-9551
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE5 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0338-9551-5050 in 1 CARTON10/05/201707/31/2019
1100 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage10/05/201707/31/2019
Labeler - Baxter Healthcare Corporation (005083209)
Establishment
NameAddressID/FEIBusiness Operations
Baxter Healthcare S.A.988899845ANALYSIS(0338-9547, 0338-9551) , LABEL(0338-9547, 0338-9551) , MANUFACTURE(0338-9547, 0338-9551) , PACK(0338-9547, 0338-9551) , STERILIZE(0338-9547, 0338-9551)

Revised: 7/2019
 
Baxter Healthcare Corporation